LT2558538T - Didelės molekulinės masės polimerai, turintys cviter-joną - Google Patents

Didelės molekulinės masės polimerai, turintys cviter-joną

Info

Publication number
LT2558538T
LT2558538T LTEP11769715.1T LT11769715T LT2558538T LT 2558538 T LT2558538 T LT 2558538T LT 11769715 T LT11769715 T LT 11769715T LT 2558538 T LT2558538 T LT 2558538T
Authority
LT
Lithuania
Prior art keywords
molecular weight
high molecular
containing polymers
zwitterion
weight zwitterion
Prior art date
Application number
LTEP11769715.1T
Other languages
English (en)
Inventor
Stephen A. Charles
Victor D. Perlroth
Didier G. Benoit
Lane A. Clizbe
Wayne To
Linda J. Zadik
Jeanne M. Pratt
Original Assignee
Kodiak Sciences Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodiak Sciences Inc. filed Critical Kodiak Sciences Inc.
Publication of LT2558538T publication Critical patent/LT2558538T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6881—Cluster-antibody conjugates, i.e. the modifying agent consists of a plurality of antibodies covalently linked to each other or of different antigen-binding fragments covalently linked to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/52—Amides or imides
    • C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/52—Amides or imides
    • C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F120/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F130/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F130/02—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/04—Polymerisation in solution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/04—Polymerisation in solution
    • C08F2/06—Organic solvent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/46—Polymerisation initiated by wave energy or particle radiation
    • C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/12—Esters of monohydric alcohols or phenols
    • C08F20/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F20/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/26—Esters containing oxygen in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F30/00—Homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F30/02—Homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00—Polymerisation catalysts
    • C08F4/06—Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen
    • C08F4/10—Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen of alkaline earth metals, zinc, cadmium, mercury, copper or silver
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2500/00—Characteristics or properties of obtained polyolefins; Use thereof
    • C08F2500/03—Narrow molecular weight distribution, i.e. Mw/Mn < 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polymerization Catalysts (AREA)
  • Polymerisation Methods In General (AREA)
  • Peptides Or Proteins (AREA)
LTEP11769715.1T 2010-04-15 2011-04-15 Didelės molekulinės masės polimerai, turintys cviter-joną LT2558538T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32441310P 2010-04-15 2010-04-15
PCT/US2011/032768 WO2011130694A2 (en) 2010-04-15 2011-04-15 High molecular weight zwitterion-containing polymers

Publications (1)

Publication Number Publication Date
LT2558538T true LT2558538T (lt) 2019-09-25

Family

ID=44799363

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP19175761.6T LT3549963T (lt) 2010-04-15 2011-04-15 Didelės molekulinės masės polimerai, kurių sudėtyje yra cviterjonai
LTEP11769715.1T LT2558538T (lt) 2010-04-15 2011-04-15 Didelės molekulinės masės polimerai, turintys cviter-joną

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP19175761.6T LT3549963T (lt) 2010-04-15 2011-04-15 Didelės molekulinės masės polimerai, kurių sudėtyje yra cviterjonai

Country Status (18)

Country Link
US (5) US20140024776A1 (lt)
EP (3) EP4029510A1 (lt)
JP (5) JP2013534931A (lt)
KR (7) KR20130097636A (lt)
CN (2) CN106432557A (lt)
AU (3) AU2011239434B2 (lt)
BR (1) BR112012026118B1 (lt)
CA (1) CA2795667C (lt)
CL (1) CL2012002881A1 (lt)
CO (1) CO6630186A2 (lt)
DK (2) DK2558538T3 (lt)
ES (2) ES2742216T3 (lt)
IL (1) IL222427A0 (lt)
LT (2) LT3549963T (lt)
MX (1) MX365521B (lt)
PT (2) PT2558538T (lt)
SI (2) SI2558538T1 (lt)
WO (1) WO2011130694A2 (lt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2657628T3 (es) 2006-02-28 2018-03-06 Kodiak Sciences Inc. Conjugados poliméricos que contienen acriloiloxietilfosforilcolina y su preparación
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
KR20130097636A (ko) * 2010-04-15 2013-09-03 올리가시스 고분자량 쌍성이온-함유 중합체
US9033159B1 (en) * 2011-06-07 2015-05-19 Clemson University Membrane surface modification
JP5907726B2 (ja) * 2011-12-28 2016-04-26 東邦化学工業株式会社 星型ポリマー及び原子移動ラジカル重合開始剤
WO2013109907A1 (en) * 2012-01-18 2013-07-25 University Of Kansas Drug and imaging agent delivery compositions and methods
JP6234064B2 (ja) * 2012-05-23 2017-11-22 キヤノン株式会社 重合体、前記重合体を用いた核磁気共鳴分析用または磁気共鳴イメージング用の造影剤、化合物、前記重合体を用いた核磁気共鳴分析方法および磁気共鳴イメージング方法
KR20150100706A (ko) * 2012-12-28 2015-09-02 블렌드 세라퓨틱스, 인코포레이티드 입자 내에 캡슐화된 표적화된 콘쥬게이트 및 이의 제형
WO2015035342A2 (en) 2013-09-08 2015-03-12 Oligasis Llc Factor viii zwitterionic polymer conjugates
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
JP6849590B2 (ja) 2014-10-17 2021-03-24 コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート
EP3188764B1 (en) * 2014-10-24 2023-08-23 Canon Kabushiki Kaisha Polymer and contrast agent for photoacoustic imaging including the polymer
AU2016246737B2 (en) * 2015-04-07 2019-11-21 Cornell University Nanoparticle immunoconjugates
CN104961853A (zh) * 2015-06-03 2015-10-07 青岛农业大学 一种新型苯乙烯微球及其制备方法
BR112018013407A2 (en) 2015-12-30 2018-12-18 Kodiak Sciences Inc. antibodies and conjugates thereof
US10548881B2 (en) 2016-02-23 2020-02-04 Tarveda Therapeutics, Inc. HSP90 targeted conjugates and particles and formulations thereof
CN105837741B (zh) * 2016-05-14 2018-01-02 上海大学 寡聚脯氨酸甲基丙烯酸酯/二甲氨乙基甲基丙烯酸酯共聚物及其制备方法
JP6870002B2 (ja) 2016-06-08 2021-05-12 重慶博藍鷹生物技術有限公司Ｃｈｏｎｇｑｉｎｇ Ｂｏｌａｎｙｉｎｇ （Ｂｌｙ） Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ．， Ｃｈｉｎａ マイクロナノ材料、その表面を親水性物質で共有結合修飾した生成物及び製造方法
CN106519147B (zh) * 2016-06-08 2017-10-17 重庆博蓝鹰生物技术有限公司 微纳米材料、其表面用亲水物质共价修饰的产物及制备方法
AU2018250695A1 (en) 2017-04-14 2019-11-07 Kodiak Sciences Inc. Complement factor D antagonist antibodies and conjugates thereof
TWI765080B (zh) 2017-08-13 2022-05-21 美商應用材料股份有限公司 藉由阻隔分子的交聯來增進選擇性沉積之方法
US11267863B2 (en) 2018-01-19 2022-03-08 Pepgene Inc. N-terminal fusion partner for producing recombinant polypeptide, and method for producing recombinant polypeptide using same
SG11202008242XA (en) 2018-03-02 2020-09-29 Kodiak Sciences Inc Il-6 antibodies and fusion constructs and conjugates thereof
CN109354637A (zh) * 2018-10-13 2019-02-19 菏泽学院 聚n-异丙基丙烯酰胺油凝胶合成方法
CN109880110B (zh) * 2019-02-15 2021-07-27 华东师范大学 含聚（2-乙烯吡啶）聚肽嵌段共聚物及其制备方法和应用
CN109912790A (zh) * 2019-03-04 2019-06-21 西南交通大学 一种具有高抗凝血性的改性聚碳酸酯
US11912784B2 (en) 2019-10-10 2024-02-27 Kodiak Sciences Inc. Methods of treating an eye disorder
EP4072590A4 (en) * 2019-12-13 2024-01-03 Folium Labs Inc. COMPLEXES COMPRISING A CARBOHYDRATE POLYMER AND AN ACTIVE INGREDIENT AND THEIR PREPARATION PROCESSES
CN110981810A (zh) * 2019-12-19 2020-04-10 东莞市维琪科技有限公司 一种脱羧肌肽的合成方法
CN111983067B (zh) * 2020-08-05 2023-03-03 河北省药品医疗器械检验研究院(河北省化妆品检验研究中心) 一种注射用拉氧头孢钠聚合物的检测方法及在线鉴定的检测方法
EP4219592A4 (en) * 2020-09-25 2024-11-06 NOF Corporation PROCESS FOR PRODUCING POLYETHYLENE GLYCOL MALEIMIDE LIPID
JP7417227B2 (ja) * 2021-01-28 2024-01-18 国立研究開発法人物質・材料研究機構 空気電池正極用の炭素多孔体の製造方法
JP7656298B2 (ja) * 2021-09-27 2025-04-03 大日精化工業株式会社 表面処理膜の製造方法
CN116270255B (zh) * 2023-02-14 2024-10-18 哈尔滨运美达生物科技有限公司 一种高贴合复合透明质酸钠修复贴及其制备方法
CN117247534B (zh) * 2023-10-20 2024-04-30 浙江恒翔新材料有限公司 一种切削液用改性超支化聚醚的制备方法及其应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162218A (en) 1988-11-18 1992-11-10 The Regents Of The University Of California Conjugated polypeptides and methods for their preparation
GB9301702D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
GB9301701D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New zwitterionic materials
US6156884A (en) 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
JP2001520009A (ja) 1997-10-16 2001-10-30 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド 鳥の導入遺伝子についてのマグナム特異的プロモーターを含むベクター
JP4162284B2 (ja) * 1998-02-04 2008-10-08 日油株式会社 洗浄剤組成物
US6781030B1 (en) 1998-11-02 2004-08-24 Trustee Of Tufts College, Ballou Hall Methods for cloning mammals using telophase oocytes
US6379942B1 (en) 1998-12-21 2002-04-30 Genencor International, Inc. Chemically modified enzymes with multiple charged variants
FR2794459B1 (fr) 1999-05-19 2004-09-03 Atofina Polyalcoxyamines issues de nitroxydes beta-substitues
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6852816B2 (en) 2000-10-06 2005-02-08 Biocompatibles Uk Limited Zwitterionic polymers
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
JP2003064132A (ja) * 2001-08-28 2003-03-05 Nof Corp 重合体、製造方法および乳化・分散剤
US6964859B2 (en) 2001-10-16 2005-11-15 Massachusetts Institute Of Technology Suppressor tRNA system
ES2566761T3 (es) 2002-05-30 2016-04-15 The Scripps Research Institute Ligación de azidas y acetilenos catalizada por cobre
DK1545613T3 (da) 2002-07-31 2011-11-14 Seattle Genetics Inc Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
WO2004069888A2 (en) * 2003-02-05 2004-08-19 Biocompatibles Uk Limited Block copolymers
CN1208358C (zh) * 2003-07-31 2005-06-29 上海交通大学 含多羟基官能团多臂星状超支化聚合物刷及其制备方法
EP1718667B1 (en) 2004-02-23 2013-01-09 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
JP4727938B2 (ja) * 2004-02-24 2011-07-20 泰彦 岩崎 リビングラジカル重合開始基を持つポリリン酸の製造方法および用途
JP4727941B2 (ja) * 2004-03-12 2011-07-20 泰彦 岩崎 生分解性重合体の製造方法および用途
JP4950022B2 (ja) 2004-03-23 2012-06-13 コンプレックス バイオシステムズ ゲーエムベーハー 自壊性リンカーを有する高分子プロドラッグ
US7632921B2 (en) 2004-11-12 2009-12-15 Bayer Healthcare Llc Site-directed modification of FVIII
DE102006009004A1 (de) * 2006-02-23 2007-09-06 Sustech Gmbh & Co. Kg Multifunktionelle sternförmige Präpolymere, deren Herstellung und Verwendung
ES2657628T3 (es) * 2006-02-28 2018-03-06 Kodiak Sciences Inc. Conjugados poliméricos que contienen acriloiloxietilfosforilcolina y su preparación
JP2007263935A (ja) * 2006-03-30 2007-10-11 Canon Inc 磁性マーカー及びその製造方法
EP2010584A4 (en) * 2006-04-14 2010-07-21 Interface Biologics Inc DIPPLETED POLYMERS AND APPLICATIONS THEREOF
WO2007130453A2 (en) 2006-05-02 2007-11-15 Allozyne, Inc. Non-natural amino acid substituted polypeptides
WO2008003099A1 (en) * 2006-06-29 2008-01-03 Invitrogen, Dynal As Particles containing multi- block polymers
CN101500548A (zh) 2006-08-18 2009-08-05 弗·哈夫曼-拉罗切有限公司 用于体内递送多核苷酸的多缀合物
JP5111016B2 (ja) * 2006-11-01 2012-12-26 三井化学株式会社 表面親水性ポリオレフィン成形体およびその製造方法
EP2097119A4 (en) * 2006-11-21 2012-10-17 Abbott Lab USE OF A TERPOLYMER OF TETRAFLUOROETHYLENE, HEXAFLUORPROPYLENE AND VINYLIDENE FLUORIDE IN MEDICAMENTAL COATINGS
WO2008098930A1 (en) * 2007-02-14 2008-08-21 Biocompatibes Uk Limited Derivatisation of biological molecules
CN101053681B (zh) * 2007-04-10 2010-05-19 天津大学 用于血管栓塞材料的温敏性MPC-b-NIPAM二嵌段星型共聚物及制备方法和应用
JP2009042617A (ja) * 2007-08-10 2009-02-26 Canon Inc 静電荷像現像用トナー及びその製造方法
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
DK2265283T3 (da) 2008-03-18 2014-10-20 Seattle Genetics Inc Auristatin-lægemiddel-linker-konjugater
HUE034763T2 (en) 2008-04-30 2018-02-28 Immunogen Inc Crosslinkers and their use
JP5344420B2 (ja) * 2008-05-15 2013-11-20 独立行政法人国立循環器病研究センター 遺伝子導入剤及びその製造方法並びに核酸複合体
WO2009138473A2 (en) * 2008-05-15 2009-11-19 Biocompatibles Uk Limited Intracellular antibody delivery
WO2010126552A1 (en) 2009-04-30 2010-11-04 Immunogen, Inc. Potent cell-binding agent drug conjugates
CN101575402B (zh) * 2009-05-31 2012-06-27 中国科学院化学研究所 一种多臂星型聚合物及其制备方法
DK2260873T3 (da) * 2009-06-08 2019-09-16 Biocompatibles Uk Ltd Pcylering af proteiner
KR101159674B1 (ko) * 2009-11-16 2012-06-25 주식회사 케이씨씨 모노실란의 정제방법
WO2011075185A1 (en) * 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
KR20130097636A (ko) 2010-04-15 2013-09-03 올리가시스 고분자량 쌍성이온-함유 중합체
BR112018013407A2 (en) * 2015-12-30 2018-12-18 Kodiak Sciences Inc. antibodies and conjugates thereof

Also Published As

Publication number Publication date
PT2558538T (pt) 2019-10-10
MX365521B (es) 2019-06-06
EP2558538A4 (en) 2016-08-17
DK3549963T3 (da) 2022-02-14
PT3549963T (pt) 2022-02-02
IL222427A0 (en) 2012-12-31
JP2018087330A (ja) 2018-06-07
CA2795667C (en) 2018-09-04
JP2020189967A (ja) 2020-11-26
KR20130097636A (ko) 2013-09-03
DK2558538T3 (da) 2019-08-05
KR20180130008A (ko) 2018-12-05
JP2016040371A (ja) 2016-03-24
AU2015207898A1 (en) 2015-08-20
US20210402015A1 (en) 2021-12-30
LT3549963T (lt) 2022-03-10
EP3549963A2 (en) 2019-10-09
JP7217245B2 (ja) 2023-02-02
WO2011130694A3 (en) 2014-03-20
AU2017201930B2 (en) 2019-04-18
ES2905690T3 (es) 2022-04-11
JP6754749B2 (ja) 2020-09-16
US20170143841A1 (en) 2017-05-25
KR20200067958A (ko) 2020-06-12
EP3549963A3 (en) 2019-12-25
KR20170137938A (ko) 2017-12-13
CL2012002881A1 (es) 2013-07-05
EP2558538A2 (en) 2013-02-20
EP4029510A1 (en) 2022-07-20
EP2558538B1 (en) 2019-07-03
CN103492489A (zh) 2014-01-01
AU2011239434A1 (en) 2012-11-08
CN106432557A (zh) 2017-02-22
KR20220039860A (ko) 2022-03-29
JP2013534931A (ja) 2013-09-09
ES2742216T3 (es) 2020-02-13
KR102416359B1 (ko) 2022-07-01
EP3549963B1 (en) 2022-01-12
KR20210084676A (ko) 2021-07-07
JP6568748B2 (ja) 2019-08-28
WO2011130694A2 (en) 2011-10-20
KR102562175B1 (ko) 2023-07-31
US20140024776A1 (en) 2014-01-23
AU2011239434B2 (en) 2015-04-30
CA2795667A1 (en) 2011-10-20
JP2022165998A (ja) 2022-11-01
CO6630186A2 (es) 2013-03-01
KR20230113857A (ko) 2023-08-01
US20200171179A1 (en) 2020-06-04
SI2558538T1 (sl) 2019-10-30
AU2017201930A1 (en) 2017-04-13
SI3549963T1 (sl) 2022-04-29
MX2012011876A (es) 2012-11-30
BR112012026118B1 (pt) 2021-01-05
US20240293585A1 (en) 2024-09-05

Similar Documents

Publication Publication Date Title
IL222427A0 (en) High molecular weight zwitterion-containing polymers
GB2494607B (en) Semiconducting polymers
EP2629760A4 (en) THERAPEUTIC NANOPARTICLES CONTAINING COPOLYMERS OF HIGH MOLECULAR WEIGHT
ZA201205562B (en) Dye polymers
EP2555741A4 (en) SPRAYABLE COMPOSITION COMPRISING A POLYMER FILLED WITH HIGH MOLECULAR WEIGHT
GB201215227D0 (en) Semiconducting polymers
HUE036018T2 (hu) Multimodális molekulasúly eloszlású polimer
GB2499099B (en) Polymer nanocomposite
GB201003970D0 (en) Polymer synthesis
PL3056520T3 (pl) Polimery zawierające silan zakończone grupami karbinolowymi
GB2493892B (en) Monomers for forming light-emitting or charge-transporting polymers
GB0915682D0 (en) Branched high molecular weight addition copolymers
ZA201208161B (en) Molecular sieve ssz-81
PL2439234T3 (pl) Kompozycja polimerowa
EP2589614A4 (en) NEW COPOLYMER
EP2617746A4 (en) NEW COPOLYMER
ZA201304292B (en) Polymer systems
ZA201300980B (en) Glatiramer acetate molecular weight markers
GB201111056D0 (en) Novel polymers
EP2603555A4 (en) POLYMER FOAM
GB201012273D0 (en) Polymer compositon
GB201007905D0 (en) Functional conjugated polymers
GB201105482D0 (en) Polymers
PL2640785T3 (pl) Polimery zakończone trialkilosililoksy
SG10201503404TA (en) Polymerization process